-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
-
Summary
-
Tvardi Therapeutics, Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and change rate from Q4 2022 to Q1 2025.
- Tvardi Therapeutics, Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 31 Mar 2025 was $1,229,000.000, a 28.5% decline year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)